While the U.S. has achieved several UNAIDS metrics for ending AIDS by 2030, goals involving the number of new infections have not been met, an assessment of U.S. Centers for Disease Control and Prevention data from 2010-2015 that was published in Clinical Infectious Diseases showed.
The aims yet to be met include a reduction in the HIV incidence rate to less than 1 per 1,000 adults and a reduction in the incidence-mortality ratio less than 1 per 10,000 adults. New seroconversions would need to fall by another 31% annually to achieve the first goal, and by 77% from 2010 levels to reach the second goal, study authors calculated.
Furthermore, progress against HIV has been uneven across geographic locations, as well as racial/ethnic and socioeconomic groups, study authors and a related commentary pointed out. In 2017, for example, HIV diagnosis rates varied from 46 per 100,000 people in Washington, D.C., to 0 in American Samoa, and diagnoses are increasing among young African-American men who have sex with men.
Scaling up HIV testing and providing sufficient medications must be part of a comprehensive effort that also considers social determinants and cultural challenges, comment authors argued.